Get started
THERAGEN ETEX CO.,LTD.THERAGEN ETEX CO.,LTD.THERAGEN ETEX CO.,LTD.

THERAGEN ETEX CO.,LTD.

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

066700 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. It operates through the following business divisions: Pharmaceutical, Specialized drug distribution, Healthcare and Genome. It offers cimetidine tabs, dimetal tabs, gabamin tabs, aclfen tab, hydone tab, other pharmaceutical products and genome analysis services. The company was founded on September 27, 1990 and is headquartered in Ansan-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
066700 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company